Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Different Spectrophotometric Methods for Quantitative Determination of Benztropine Mesylate in Presence of Its Carcinogenic Degradation Product

Different Spectrophotometric Methods for Quantitative Determination of Benztropine Mesylate in... AbstractThree simple, accurate, sensitive and selective spectrophotometric stability-indicating methods for determination of Benztropine Mesylate (BNZ) in the presence of its hepatotoxic and carcinogenic degradation product; Benzophenone (BPH); were developed and validated without preliminary separation. The developed spectrophotometric methods are; first derivative, first derivative of ratio spectra and ratio difference were developed for the determination of BNZ in the presence of BPH in pure form and in pharmaceutical formulation. The most important advantage of this work is that it is the first time to develop spectrophotometric methods for determination of BNZ and its carcinogenic degradation product. BNZ was subjected to stress degradation conditions (acid, alkaline and oxidation), and the obtained degradate was confirmed to be BPH. Calibration curves of these methods are linear over the concentration ranges of 5-20 and 3-20 μg mL−1 for BNZ and BPH, respectively. Method (I); first derivative spectrophotometric method where BNZ was measured at 228.2 nm. Method (II); first derivative of ratio spectra spectrophotometric one where the overlapping spectra of BNZ and BPH were well resolved and BNZ was measured at peak amplitude 228.8 nm. Method (III); ratio difference spectrophotometric method which depends on measuring difference in peak amplitude values between two different wavelengths of the ratio spectrum at 224 and 234 nm for determination of BNZ. While BPH was determined by the first derivative at 245 NM without interference from BNZ. The proposed methods were successfully applied for determination of the studied drug in its pharmaceutical formulation. These methods were validated according to ICH guidelines. Results obtained by applying the proposed methods were statistically analyzed and compared with those obtained by reported one using F and student’s t-tests showed no significant difference was obtained regarding both accuracy and precision. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Analytical Chemistry Letters Taylor & Francis

Different Spectrophotometric Methods for Quantitative Determination of Benztropine Mesylate in Presence of Its Carcinogenic Degradation Product

Download PDF

Different Spectrophotometric Methods for Quantitative Determination of Benztropine Mesylate in Presence of Its Carcinogenic Degradation Product

Abstract

AbstractThree simple, accurate, sensitive and selective spectrophotometric stability-indicating methods for determination of Benztropine Mesylate (BNZ) in the presence of its hepatotoxic and carcinogenic degradation product; Benzophenone (BPH); were developed and validated without preliminary separation. The developed spectrophotometric methods are; first derivative, first derivative of ratio spectra and ratio difference were developed for the determination of BNZ in the presence of BPH in...
Loading next page...
 
/lp/taylor-francis/different-spectrophotometric-methods-for-quantitative-determination-of-CEwQGqtxs8
Publisher
Taylor & Francis
Copyright
© 2017 Har Krishan Bhalla & Sons
ISSN
2230-7532
eISSN
2229-7928
DOI
10.1080/22297928.2017.1322533
Publisher site
See Article on Publisher Site

Abstract

AbstractThree simple, accurate, sensitive and selective spectrophotometric stability-indicating methods for determination of Benztropine Mesylate (BNZ) in the presence of its hepatotoxic and carcinogenic degradation product; Benzophenone (BPH); were developed and validated without preliminary separation. The developed spectrophotometric methods are; first derivative, first derivative of ratio spectra and ratio difference were developed for the determination of BNZ in the presence of BPH in pure form and in pharmaceutical formulation. The most important advantage of this work is that it is the first time to develop spectrophotometric methods for determination of BNZ and its carcinogenic degradation product. BNZ was subjected to stress degradation conditions (acid, alkaline and oxidation), and the obtained degradate was confirmed to be BPH. Calibration curves of these methods are linear over the concentration ranges of 5-20 and 3-20 μg mL−1 for BNZ and BPH, respectively. Method (I); first derivative spectrophotometric method where BNZ was measured at 228.2 nm. Method (II); first derivative of ratio spectra spectrophotometric one where the overlapping spectra of BNZ and BPH were well resolved and BNZ was measured at peak amplitude 228.8 nm. Method (III); ratio difference spectrophotometric method which depends on measuring difference in peak amplitude values between two different wavelengths of the ratio spectrum at 224 and 234 nm for determination of BNZ. While BPH was determined by the first derivative at 245 NM without interference from BNZ. The proposed methods were successfully applied for determination of the studied drug in its pharmaceutical formulation. These methods were validated according to ICH guidelines. Results obtained by applying the proposed methods were statistically analyzed and compared with those obtained by reported one using F and student’s t-tests showed no significant difference was obtained regarding both accuracy and precision.

Journal

Analytical Chemistry Letters – Taylor & Francis

Published: May 4, 2017

Keywords: Benztropine; Benzophenone; Derivative spectrophotometry; Stability indicating method

References

  • Carcinogenesis studies of benzophenone in rats and mice
  • Toxicological evaluation of benzophenone
  • Metabolism and toxicity of benzophenone in isolated rat hepatocytes and estrogenic activity of its metabolites in MCF-7 cells
  • A stable isotope dilution assay for the antiparkinsonian drug benztropine in biological fluids
  • High-performance liquid chromatographic method for the analysis of benztropine in human plasma
  • Simultaneous determination of benztropine mesylate and benzophenone by high-performance liquid chromatography
  • Development and validation of three spectrophotometric methods for determination of pyridostigmine bromide in the presence of its alkaline induced degradation product in the presence of its alkaline induced degradation product
  • A new spectrophotometric method for quantitative multicomponent analysis resolution of mixtures of salicylic and salicyluric acids
  • Application of ratio derivative spectrophotometry for simultaneous determination of naphazoline and antazoline in eye drops
  • Spectrophotometric determination of isopropamide Iodide and trifluoperazine hydrochloride in presence of trifluoperazine oxidative degradate
  • Spectrophotometric methods for the determination of fluconazole in the presence of its oxidative degradation product
  • Comparative study of novel spectrophotometric methods manipulating ratio spectra/ : An application on pharmaceutical ternary mixture of omeprazole, tinidazole and clarithromycin. Spectrochim. ACTA PART A Mol. Biomol
  • A smart simple spectrophotometric method for simultaneous determination of binary mixtures
  • Modern spectrophotometric methods for quantitative determination of binary mixture of hydrochlorothiazide and amiloride hydrochloride without prior separation